EDSA Insider Trading Activity and SEC Form 4 Filings
EDSA insider trading summary
Over the past 12 months, insiders at Edesa Biotech, Inc. (EDSA) reported 8 open-market purchases worth $230K by 1 insider and no sales on SEC Form 4. Net insider buying was $230K.
Latest EDSA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 10, 2026 | Pardeep Nijhawan | Chief Executive Officer | Buy | $7K (1,000 @ $6.60) |
| Mar 5, 2026 | Pardeep Nijhawan | Chief Executive Officer | Buy | $39K (10,000 @ $3.90) |
| Mar 4, 2026 | Pardeep Nijhawan | Chief Executive Officer | Buy | $43K (10,000 @ $4.26) |
| Mar 3, 2026 | Pardeep Nijhawan | Chief Executive Officer | Buy | $36K (10,000 @ $3.63) |
| Mar 2, 2026 | Pardeep Nijhawan | Chief Executive Officer | Buy | $4K (2,000 @ $2.00) |
| Mar 2, 2026 | Pardeep Nijhawan | Chief Executive Officer | Buy | $2K (1,000 @ $2.28) |
| Feb 27, 2026 | Pardeep Nijhawan | Chief Executive Officer | Buy | $67K (30,000 @ $2.22) |
| Feb 26, 2026 | Pardeep Nijhawan | Chief Executive Officer | Buy | $32K (20,571 @ $1.58) |
| Mar 25, 2024 | Pardeep Nijhawan Medicine Professional Corp | Insider | Buy | $20K (5,000 @ $4.00) |
| Mar 25, 2024 | Pardeep Nijhawan | Chief Executive Officer | Buy | $20K (5,000 @ $4.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.